从活性氧到癌细胞死亡:光动力学治疗背后的科学
Elaheh Gheybi1, Pejman Hosseinzadeh2, Vahid Tayebi-Khorrami3
1Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Lasers in medical science
|October 20, 2025
概括
光动力疗法 (PDT) 通过使用光敏感药物和特定的光波长来产生杀死细胞的活性氧物种,提供了最少的侵入性癌症治疗. 本综述探讨了PDT的原则,重点关注光敏剂,光参数和瘤氧气水平,以提高治疗的有效性.
科学领域:
- 在瘤学瘤学.
- 生物化学 生化学
- 医学物理 医学物理
背景情况:
- 光动力疗法 (PDT) 是一种新兴的,微创的瘤治疗方法,已被批准用于各种癌症.
- PDT利用特定光波长激活的光敏化剂来产生反应性氧物种 (ROS).
- ROS诱导细胞损伤,导致癌细胞死亡,是这种治疗方法的基础.
研究的目的:
- 综合审查光动力疗法 (PDT) 的基本原则.
- 批判性地分析影响PDT有效性的关键组件:光敏剂设计,辐射参数和瘤微环境氧化.
- 要强调这些因素在优化用于瘤学应用的PDT方面的集体重要性.
主要方法:
- 文献综述,重点关注光敏剂的开发和表征.
- 对PDT的光输送系统和剂量计的分析.
- 检查瘤氧气水平的作用和调节瘤氧气水平的策略.
主要成果:
- 优化的光敏剂设计对于有效的光吸收和ROS生成至关重要.
- 精确控制辐射参数 (波长,剂量,持续时间) 对于最大限度地提高治疗效果和最大限度地减少副作用至关重要.
- 瘤氧化显著影响PDT的疗效,缺氧往往会降低治疗结果.
结论:
- PDT的有效性是一个多因素的过程,取决于光敏剂,光和瘤微环境之间的相互作用.
- 对新型光敏感剂,先进的光输送技术和克服瘤缺氧的方法的进一步研究可以显著改善PDT的结果.
- 优化这些核心原则对于推动PDT成为主流的瘤治疗至关重要.
相关概念视频
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
01:46Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
02:53Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K